Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: betty moyers who wrote (10431)	7/4/1998 10:10:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

betty, Here is another way to look at things: Men who have a heart attack shortly after taking their Viagra can not be given nitro as a part of the acute treatment protocol for heart attack victims. In other words men who are candidates for coronaries need to decide if Viagra is more important than being saved from a heart attack--apparently the FDA thinks so. Kind of sad that the FDA could not figure this simple scenario out and have Pfizer place such a warning on the label. It's kind of like putting the cart in front of the horse.